Data Explorations
Multiplexed 3D atlas of state transitions and immune interactions in colorectal cancer (CRC01 Z-stack)
Graphical Abstract - Multiplexed 3D atlas of state transitions and immune interactions in colorectal cancer
Pathological annotations - Multiplexed 3D atlas of state transitions and immune interactions in colorectal cancer - CRC01
P138007
P137974
P137941
P137905
P137757
P137753
P137591
P136690
P133537
P132666
P132630
P132115
Exploring the Stages of Tuberculosis Granulomas
Clinical Features of Tuberculosis Granulomas
BRCA1-Associated Triple Negative Breast Cancer
Combination Therapy in Ovarian Cancer
Murine Models of Lung Adenocarcinoma
Lung Adenocarcinoma Metastasis to Lymph Node
Primary Squamous Cell Carcinoma of the Lung
Temporal and spatial topography of cell proliferation in cancer
crc-case-1-ffpe-cycif-pilot
A8_right_ventricle
A7_lateral_left_ventricle
A6_posterior_left_ventricle
A5_posterior_left_ventricle
A4_posterior_left_ventricle
A3_interventricular_septum
A2_anterior_left_ventricle
A20_left_circumflex_artery
A1_left_atrium
A19_left_anterior_descending_artery
A18_left_anterior_descending_artery
A17_mid_distal_right_coronary_artery
Patient 1 - Melanoma with precursor fields
Patient 2 - Melanoma in situ, invasive melanoma, precursor field and inflammatory regression
Patient 2 - Inflammatory regression and brisk TILs
Patient 2 - Melanoma in situ, invasive and polypoid melanoma
MEL13-2-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL13-2-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL13-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL13-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL12-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL12-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL11-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL11-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL10-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL10-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
Deep Exploration of a Primary Melanoma (MEL 1 Full Story)
Introduction to the MEL Atlas (MEL 1 Abstract)
MEL09-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL09-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL08-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL08-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL07-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL07-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL06-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL06-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL05-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL05-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL04-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL04-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL03-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL03-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL02-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL02-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-3-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-3-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-2-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-2-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-1-6 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-1-5 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-1-4 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-1-3 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-1-1 - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
MEL01-1-0 - H&E - overview - Nirmal, Maliga, Vallius, Sorger et al., 2021
Z147
Ovarian Cancer with Annotation - LSP15343
Ovarian Cancer with Annotation - LSP15327
MITI - LSP15343
LSP16696
LSP16697
LSP16698
LSP16699
LSP16814
CK1 (BRCA wildtype)
CK2 (BRCA wildtype)
CK3_R (BRCA wildtype)
CK4_P (BRCA wildtype)
CK4_R (BRCA wildtype)
CK5 (BRCA wildtype)
CK6 (BRCA wildtype)
CK7 (BRCA wildtype)
CK8 (BRCA wildtype)
CK9 (BRCA wildtype)
CK10 (BRCA wildtype)
CK11 (BRCA wildtype)
CK12 (BRCA wildtype)
CK13 (BRCA wildtype)
CK14 (BRCA wildtype)
CK15 (BRCA wildtype)
CK16 (BRCA wildtype)
CK17_M (BRCA wildtype)
CK18_P (BRCA wildtype)
CK19_BCC (BRCA wildtype)
CK19_BCC2 (BRCA wildtype)
CK20 (BRCA wildtype)
CK21 (BRCA wildtype)
CK22 (BRCA wildtype)
CK23 (BRCA wildtype)
CK24 (BRCA wildtype)
CK25_R (BRCA wildtype)
CK26 (BRCA wildtype)
W2BC_3 (BRCA wildtype)
W8B_4 (BRCA wildtype)
K1 (BRCA mutant)
K2 (BRCA mutant)
K3 (BRCA mutant)
K4 (BRCA mutant)
K5 (BRCA mutant)
K6 (BRCA mutant)
K7 (BRCA mutant)
K8 (BRCA mutant)
K9 (BRCA mutant)
K10 (BRCA mutant)
K11 (BRCA mutant)
K12 (BRCA mutant)
K13 (BRCA mutant)
K14 (BRCA mutant)
K15 (BRCA mutant)
K16 (BRCA mutant)
K17 (BRCA mutant)
K18 (BRCA mutant)
K19 (BRCA mutant)
K20 (BRCA mutant)
K21 (BRCA mutant)
K22 (BRCA mutant)
K23 (BRCA mutant)
K24 (BRCA mutant)
K26 (BRCA mutant)
K27 (BRCA mutant)
jenntnbc4m33118
BRCA1-associated-9
BRCA1-associated-8
BRCA1-associated-7
BRCA1-associated-6
BRCA1-associated-5
BRCA1-associated-4
BRCA1-associated-3
BRCA1-associated-2
BRCA1-associated-10
BRCA1-associated-1
BRCA WT vs BRCA1 associated TNBC
BRCA-WT-6
BRCA-WT-5
BRCA-WT-4
BRCA-WT-3
BRCA-WT-2
BRCA-WT-1
Liu et al, 2019 - PP
Liu et al, 2019 - PO
Liu et al, 2019 - PM
Liu et al, 2019 - PL
Liu et al, 2019 - PK
Liu et al, 2019 - PJ
Liu et al, 2019 - PH
Liu et al, 2019 - PG
Liu et al, 2019 - PF
Liu et al, 2019 - PE
Liu et al, 2019 - PC
Liu et al, 2019 - PB
Liu et al, 2019 - PA
Liu et al, 2019 - P9
Liu et al, 2019 - P8
Liu et al, 2019 - P7
Liu et al, 2019 - P6
Liu et al, 2019 - P5
Liu et al, 2019 - P4
Liu et al, 2019 - P2
Liu et al, 2019 - P1
Liu et al, 2019 - N3
Liu et al, 2019 - N2
Liu et al, 2019 - N1
Liu et al, 2019 - AV1
Liu et al, 2019 - AS4
Liu et al, 2019 - AS3
Liu et al, 2019 - AS2
Liu et al, 2019 - AS1
Liu et al, 2019 - AL4
Liu et al, 2019 - AL3
Liu et al, 2019 - AL2
Liu et al, 2019 - AL1
Orion CRC40 - overview - Lin, Chen, Campton et al., 2023
Orion CRC39 - overview - Lin, Chen, Campton et al., 2023
Orion CRC38 - overview - Lin, Chen, Campton et al., 2023
Orion CRC37 - overview - Lin, Chen, Campton et al., 2023
Orion CRC36 - overview - Lin, Chen, Campton et al., 2023
Orion CRC35 - overview - Lin, Chen, Campton et al., 2023
Orion CRC34 - overview - Lin, Chen, Campton et al., 2023
Orion CRC33_02 - overview - Lin, Chen, Campton et al., 2023
Orion CRC33_01 - overview - Lin, Chen, Campton et al., 2023
Orion CRC32 - overview - Lin, Chen, Campton et al., 2023
Orion CRC31 - overview - Lin, Chen, Campton et al., 2023
Orion CRC30 - overview - Lin, Chen, Campton et al., 2023
Orion CRC29 - overview - Lin, Chen, Campton et al., 2023
Orion CRC28 - overview - Lin, Chen, Campton et al., 2023
Orion CRC27 - overview - Lin, Chen, Campton et al., 2023
Orion CRC26 - overview - Lin, Chen, Campton et al., 2023
Orion CRC25 - overview - Lin, Chen, Campton et al., 2023
Orion CRC24 - overview - Lin, Chen, Campton et al., 2023
Orion CRC23 - overview - Lin, Chen, Campton et al., 2023
Orion CRC22 - overview - Lin, Chen, Campton et al., 2023
Orion CRC21 - overview - Lin, Chen, Campton et al., 2023
Orion CRC08 - overview - Lin, Chen, Campton et al., 2023
Orion CRC20 - overview - Lin, Chen, Campton et al., 2023
Orion CRC19 - overview - Lin, Chen, Campton et al., 2023
Orion CRC18 - overview - Lin, Chen, Campton et al., 2023
Orion CRC17 - overview - Lin, Chen, Campton et al., 2023
Orion CRC16 - overview - Lin, Chen, Campton et al., 2023
Orion CRC15 - overview - Lin, Chen, Campton et al., 2023
Orion CRC14 - overview - Lin, Chen, Campton et al., 2023
Orion CRC13 - overview - Lin, Chen, Campton et al., 2023
Orion CRC12 - overview - Lin, Chen, Campton et al., 2023
Orion CRC11 - overview - Lin, Chen, Campton et al., 2023
Orion CRC10 - overview - Lin, Chen, Campton et al., 2023
Orion CRC09 - overview - Lin, Chen, Campton et al., 2023
Orion CRC07 - overview - Lin, Chen, Campton et al., 2023
Orion CRC06 - overview - Lin, Chen, Campton et al., 2023
Orion CRC05 - overview - Lin, Chen, Campton et al., 2023
Orion CRC04 - overview - Lin, Chen, Campton et al., 2023
Orion CRC03 - overview - Lin, Chen, Campton et al., 2023
Orion CRC02 - overview - Lin, Chen, Campton et al., 2023
Orion CRC01 - overview - Lin, Chen, Campton et al., 2023
CRC18 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC17 - overview - Lin, Wang, Coy et al., 2021
CRC17 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC16 - overview - Lin, Wang, Coy et al., 2021
CRC16 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC15 - overview - Lin, Wang, Coy et al., 2021
CRC15 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC14 - overview - Lin, Wang, Coy et al., 2021
CRC14 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC13 - overview - Lin, Wang, Coy et al., 2021
CRC13 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC12 - overview - Lin, Wang, Coy et al., 2021
CRC12 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC11 - overview - Lin, Wang, Coy et al., 2021
CRC11 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC10 - overview - Lin, Wang, Coy et al., 2021
CRC10 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC08 - overview - Lin, Wang, Coy et al., 2021
CRC09 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC08 - overview - Lin, Wang, Coy et al., 2021
CRC08 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC07 - overview - Lin, Wang, Coy et al., 2021
CRC07 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC06 - overview - Lin, Wang, Coy et al., 2021
CRC06 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC05 - overview - Lin, Wang, Coy et al., 2021
CRC05 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC04 - overview - Lin, Wang, Coy et al., 2021
CRC04 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC03 - overview - Lin, Wang, Coy et al., 2021
CRC03 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC02 - overview - Lin, Wang, Coy et al., 2021
CRC02 - H&E - overview - Lin, Wang, Coy et al., 2021
CRC01 - overview - Lin, Wang, Coy et al., 2021
CRC01 - H&E - overview - Lin, Wang, Coy et al., 2021
Pathological Annotations - CRC01 - Lin, Wang, Coy et al, 2021
CRC01 - 25 CyCIF sections - Lin, Wang, Coy et al, 2021
Figure 7 and 8
Figure 2
Figure 11 and 12
Figure 10
Clinical Benefit - Cisplatin Biopsy
Clinical Benefit - Cis Wee1i Biopsy
No Clinical Benefit - Cis Wee1i Biopsy
No Clinical Benefit - Cisplatin Biopsy
Colon Adenocarcinoma - Gaglia et al, 2018 - Case 1
Genetically engineered mouse model of lung adenocarcinoma
Temporal and spatial topography of cell proliferation in cancer
Tonsils IHC - Du and Lin et al
Tonsils 1 - Du and Lin et al
Lung 3 Data Analysis - Du and Lin et al
Lung 3 - Du and Lin et al
Lung 2 - Du and Lin et al
Lung 1 - Du and Lin et al
Plexiform Schwannoma (Spinal Nerve Root)
Plexiform Schwannoma (Soft Tissue)
Plexiform Schwannoma (Soft Tissue)
Intraneural Schwannoma (Finger)
Plexiform Schwannoma (Finger)
Plexiform Schwannoma (Larynx)
Plexiform Schwannoma (Larynx)
Schwannoma (Spinal Nerve Root)
Schwannoma (Spinal Nerve Root)
Schwannoma (Spinal Nerve Root)
Vestibular Schwannoma 2
Meningioma
Vestibular Schwannoma 1
Vestibular Schwannoma 1
Meningioma
Multimodal spatial profiling of colorectal cancer using Orion